Bodegraven AAV, Mulder CJ. Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete? World J Gastroenterol 2006; 12(38): 6115-6123 [PMID: 17036381 DOI: 10.3748/wjg.v12.i38.6115]
Corresponding Author of This Article
Ad van Bodegraven, Department of Gastroenterology, VU University medical centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. v.bodegraven@vumc.nl
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/